BioSpace News Archive

BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, has announced the completion of a $200M private financing of its former subsidiary, TheRas, Inc. d/b/a BridgeBio Oncology Therapeutics, to accelerate the development of its oncology portfolio.

Prelude Corporation, a leader in precision diagnostics for early-stage breast cancer, announced the appointment of Dr. Pat Whitworth as its new Chief Medical Officer.

Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, reported financial results and business highlights for the first quarter ended March 31, 2024.

Ginkgo Bioworks Holdings, Inc. announced that it plans to host a presentation and Q&A session reviewing business performance for the first quarter ended March 31, 2024, on Thursday, May 9, 2024, beginning at 5:30 p.m. ET.

Alpha-9 Oncology announced that the first participant has been dosed in the Phase 1 study evaluating 68Ga-A9-3202, a radiodiagnostic targeting melanocortin 1 receptor for the imaging of locally advanced or metastatic melanoma.

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced that results from the ibezapolstat Phase 2 clinical trial in patients with C. difficile Infection were presented at the 34th Congress of ESCMID Global on April 30th which was held in Barcelona, Spain, April 27-30, 2024.

Zoetis Inc. reported its financial results for the first quarter of 2024 and updated its guidance for full year 2024.

Bruker Corporation announced financial results for its first quarter ended March 31, 2024.

Delphia Therapeutics, Inc., announced its launch to pioneer a new area of cancer biology – activation lethality – which targets cancer’s surprising vulnerability to oncogene overactivation.

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (“Bausch Health” or the “Company” or “we” or “our”) today announced its first quarter 2024 financial results and other key updates from the quarter.